Diabetic foot infection versus non-infected diabetic foot: contemporary diagnostic criteria, management algorithms, and clinical pitfalls: a focus on differentiating infectious and ischemic etiologies in diabetic foot ulcers
DOI:
https://doi.org/10.18203/2320-6012.ijrms20251678Keywords:
Diabetic foot infection, Diabetic foot ulcer, Critical limb ischemia, Osteomyelitis, IDSA/IWGDF guidelines, MisdiagnosisAbstract
Diabetic foot ulcers (DFUs) represent a significant complication of diabetes mellitus, with infection (DFI) and critical limb ischemia (CLI) being key determinants of morbidity and amputation risk. Despite established guidelines from the infectious diseases society of America (IDSA) and the international working group on the diabetic foot (IWGDF), misdiagnosis between infected and non-infected (particularly ischemic) DFUs remains a frequent clinical challenge, leading to inappropriate antimicrobial therapy or delayed revascularization. This review examines the current diagnostic criteria for DFI, contrasts them with ischemic presentations, and highlights common errors in management, emphasizing evidence-based strategies to optimize outcomes. A narrative synthesis of IDSA/IWGDF guidelines, recent literature on DFU classification systems (e.g., SINBAD, WIfI), and clinical studies on biomarkers (e.g., procalcitonin, CRP) and imaging modalities (MRI, PET-CT) was conducted. Key discriminators between DFI and CLI include localized vs. diffuse erythema, systemic inflammatory response, and perfusion assessment (ABI, TcPO₂). Overreliance on superficial wound cultures and underutilization of bone biopsy in osteomyelitis are recurrent errors. Multidisciplinary teams (MDTs) integrating infectious disease, vascular surgery, and podiatry reduce misclassification rates. Distinguishing DFI from CLI requires systematic evaluation of clinical, laboratory, and vascular parameters. Enhanced clinician awareness of IDSA/IWGDF criteria and ischemic mimics may reduce diagnostic errors and improve limb salvage rates.
Metrics
References
International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Belgium. 2021. Available at: https://www.diabetesatlas.org. Accessed on 12 February 2025.
Raspovic KM, Wukich DK. Self-reported quality of life and diabetic foot infections. J Foot Ankle Surg. 2014;53(6):716-9. DOI: https://doi.org/10.1053/j.jfas.2014.06.011
Peters EJ, Childs MR, Wunderlich RP, Harkless LB, Armstrong DG, Lavery LA. Functional status of persons with diabetes-related lower extremity amputations. Diabetes Care. 2001;24(10):1799-804. DOI: https://doi.org/10.2337/diacare.24.10.1799
Lavery LA, Armstrong DG, Murdoch DP, Peters EJ, Lipsky BA. Validation of the Infectious Diseases Society of America's diabetic foot infection classification system. Clin Infect Dis. 2007;44(4):562-5. DOI: https://doi.org/10.1086/511036
Ndosi M, Wright-Hughes A, Brown S, Backhouse M, Lipsky BA, Bhogal M, et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med. 2018;35(1):78-88. DOI: https://doi.org/10.1111/dme.13537
Tan TW, Shih CD, Concha-Moore KC, Muhanad MD, Bo H, David M, et al. Disparities in outcomes of patients admitted with diabetic foot infections. PLoS One. 2019;14(2):e0211481. DOI: https://doi.org/10.1371/journal.pone.0211481
Fitridge R, Chuter V, Mills J, Hinchliffe R, Azuma N, Behrendt CA, et al. The intersocietal IWGDF, ESVS, SVS guidelines on peripheral artery disease in people with diabetes mellitus and a foot ulcer. Diab Metab Res Rev. 2024;40(3):e3686. DOI: https://doi.org/10.1002/dmrr.3686
Chen P, Campillo Vilorio N, Dhatariya K, Jeffcoate W, Lobmann R, McIntosh C, et al. Guidelines on interventions to enhance healing of foot ulcers in people with diabetes (IWGDF 2023 update). Diab Metab Res Rev. 2024;40(3):e3644. DOI: https://doi.org/10.1002/dmrr.3786
Monteiro-Soares M, Hamilton EJ, Russell DA, Gulapar S, Edward JB, Joseph LM, et al. Guidelines on the classification of foot ulcers in people with diabetes (IWGDF 2023 update). Diab Metab Res Rev 2023;40(3):e3648. DOI: https://doi.org/10.1002/dmrr.3648
Lipsky BA, Berendt AR, Deery HG, John ME, Warren SJ, Adolf WK, et al. Diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2004;39(7):885-910. DOI: https://doi.org/10.1086/424846
Lipsky BA, Berendt AR, Cornia PB, James CP, Edgar JGP, David GA, et al. Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin Infect Dis. 2012;54(12):e132-73. DOI: https://doi.org/10.1093/cid/cis346
Peters EJ, Lipsky BA, Aragon-Sanchez J, Boyko EJ, Diggle M, Embil JM, et al. Interventions in the management of infection in the foot in diabetes: a systematic review. Diab Metab Res Rev. 2016;32(1):145-53. DOI: https://doi.org/10.1002/dmrr.2706
Lipsky BA, Senneville É, Abbas ZG, Aragón-Sánchez J, Diggle M, Embil JM, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diab Metab Res Rev. 2020;36(1):e3280. DOI: https://doi.org/10.1002/dmrr.3280
Peters EJ, Lipsky BA. Diagnosis and management of infection in the diabetic foot. Med Clin North Am. 2013;97(5):911-46. DOI: https://doi.org/10.1016/j.mcna.2013.04.005
Lavery LA, Armstrong DG, Wunderlich RP, Mohler MJ, Wendel CS, Lipsky BA. Risk factors for foot infections in individuals with diabetes. Diabetes Care. 2006;29(6):1288-93. DOI: https://doi.org/10.2337/dc05-2425